Related Experiment Video
Updated: Jun 14, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Ex-PRESS miniature glaucoma device in vitrectomized eyes
Michele Vetrugno1, Paolo Ferreri, Carlo Sborgia
1Department of Ophthalmology-Otolaryngology, University of Bari, Bari, Italy. m.vetrugno@oftalmo.uniba.it
European Journal of Ophthalmology
|March 23, 2010
Summary
The Ex-PRESS glaucoma device effectively lowered intraocular pressure (IOP) in patients with ocular hypertension after vitreoretinal surgery. This surgical approach demonstrated significant IOP reduction, with some patients achieving target levels without medication.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Vitreoretinal Surgery
Background:
- Persistent ocular hypertension following vitreoretinal surgery poses a challenge.
- Glaucoma surgery is often necessary to manage elevated intraocular pressure (IOP) in these patients.
Observation:
- The Ex-PRESS miniature glaucoma device was implanted under a scleral flap in vitrectomized patients.
- Clinical outcomes and IOP were monitored for six months post-implantation.
Findings:
- All patients achieved an IOP below 18 mmHg at the 6-month follow-up.
- Three patients were able to discontinue topical IOP-lowering medications.
Implications:
- The Ex-PRESS implant offers an effective surgical option for managing ocular hypertension in post-vitreoretinal surgery eyes.
- This technique may reduce the need for medical therapy in select glaucoma patients.
